Anneliza Andreadi
Dr Vicky Brocklebank
Dr Patrick Walsh
Professor David Steel
Professor Claire Harris
et al. | The Role of Complement Factor I Rare Genetic Variants in Age Related Macular Degeneration in Finland | 2025 |
|
Anneliza Andreadi
Dr Vicky Brocklebank
Professor Kevin Marchbank
Professor Claire Harris
Professor David Kavanagh
et al. | Comprehensive functional characterization of complement factor I rare variant genotypes identified in the SCOPE geographic atrophy cohort | 2024 |
|
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Megan Bates
et al. | Description and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort | 2024 |
|
Dr Sally Johnson
Professor David Kavanagh
Professor John Sayer
Dr Edwin Wong
Dr Vicky Brocklebank
et al. | Effects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort | 2024 |
|
Professor David Kavanagh
Dr Vicky Brocklebank
Dr Sally Johnson
Professor Neil Sheerin
| Outcomes from the International Society of Nephrology Hemolytic Uremic Syndromes International Forum | 2024 |
|
Dr Edwin Wong
Lee-Ann Naidoo
Sarah Winn
Dr Patrick Walsh
Dr Vicky Brocklebank
et al. | The Annual Report of the National Renal Complement Therapeutics Centre 2022/23 | 2024 |
|
Emily Glover
Dr Kate Smith-Jackson
Dr Vicky Brocklebank
Dr Valerie Wilson
Dr Patrick Walsh
et al. | Assessing the Impact of Prophylactic Eculizumab on Renal Graft Survival in Atypical Hemolytic Uremic Syndrome | 2023 |
|
Dr Vicky Brocklebank
Dr Patrick Walsh
Dr Kate Smith-Jackson
Dr Thomas Hallam
Professor Kevin Marchbank
et al. | Atypical haemolytic uraemic syndrome in the era of terminal complement inhibition- An observational cohort study | 2023 |
|
